MX2007010243A - Compuestos de 1,1,1-trifluoro-3-[(bencil)-(pirimidin-2-il)-amino]- propan-2-ol sustituidos. - Google Patents
Compuestos de 1,1,1-trifluoro-3-[(bencil)-(pirimidin-2-il)-amino]- propan-2-ol sustituidos.Info
- Publication number
- MX2007010243A MX2007010243A MX2007010243A MX2007010243A MX2007010243A MX 2007010243 A MX2007010243 A MX 2007010243A MX 2007010243 A MX2007010243 A MX 2007010243A MX 2007010243 A MX2007010243 A MX 2007010243A MX 2007010243 A MX2007010243 A MX 2007010243A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- cholesterol
- pyrimidin
- trifluoro
- benzyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Compuestos de 1,1,1-trifluoro-3-[(bencil)-(pirimidin-2-il)-amino]- propan-2-ol sustituidos, composiciones farmaceuticas que contienen tales compuestos y uso de tales compuestos para elevar ciertos niveles de lipido en plasma, incluyendo colesterol - lipoproteina de alta densidad y para reducir otros niveles de lipido en plasma, tales como colesterol LDL y trigliceridos y de acuerdo con lo anterior tratar enfermedades que se vean afectadas por bajos niveles de colesterol HDL y/o altos niveles de colesterol LDL y trigliceridos, tales como aterosclerosis y enfermedades cardiovasculares en algunos mamiferos, incluyendo humanos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65574005P | 2005-02-23 | 2005-02-23 | |
PCT/IB2006/000374 WO2006090250A1 (en) | 2005-02-23 | 2006-02-13 | Substituted 1,1,1-trifluoro-3-[(benzyl)-(pyrimidin-2-yl)-amino]-prop an-2-ol compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007010243A true MX2007010243A (es) | 2007-09-07 |
Family
ID=36215578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007010243A MX2007010243A (es) | 2005-02-23 | 2006-02-13 | Compuestos de 1,1,1-trifluoro-3-[(bencil)-(pirimidin-2-il)-amino]- propan-2-ol sustituidos. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20100130784A1 (es) |
EP (1) | EP1856060A1 (es) |
JP (1) | JP2008545617A (es) |
KR (1) | KR20070096041A (es) |
CN (1) | CN101128438A (es) |
AU (1) | AU2006217630A1 (es) |
BR (1) | BRPI0607839A2 (es) |
CA (1) | CA2598869A1 (es) |
IL (1) | IL184677A0 (es) |
MX (1) | MX2007010243A (es) |
RU (1) | RU2007131537A (es) |
WO (1) | WO2006090250A1 (es) |
ZA (1) | ZA200705972B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
US7790770B2 (en) * | 2005-11-23 | 2010-09-07 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
CN101663262B (zh) | 2006-12-01 | 2014-03-26 | 百时美施贵宝公司 | 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物 |
JP4834699B2 (ja) * | 2007-07-30 | 2011-12-14 | 田辺三菱製薬株式会社 | 医薬組成物 |
US20120179035A1 (en) * | 2011-01-07 | 2012-07-12 | General Electric Company | Medical device with motion sensing |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE296796T1 (de) * | 1998-09-25 | 2005-06-15 | Monsanto Co | (r)-chirale halogenierte 1-substituierte amino- (n+1)-alkanolen für die hemmung der aktivität des cholesteryl-ester-transfer-proteins |
-
2006
- 2006-02-13 JP JP2007556678A patent/JP2008545617A/ja active Pending
- 2006-02-13 CN CNA2006800058580A patent/CN101128438A/zh active Pending
- 2006-02-13 MX MX2007010243A patent/MX2007010243A/es unknown
- 2006-02-13 KR KR1020077019171A patent/KR20070096041A/ko active IP Right Grant
- 2006-02-13 EP EP06710438A patent/EP1856060A1/en not_active Withdrawn
- 2006-02-13 RU RU2007131537/04A patent/RU2007131537A/ru not_active Application Discontinuation
- 2006-02-13 WO PCT/IB2006/000374 patent/WO2006090250A1/en active Application Filing
- 2006-02-13 US US11/720,765 patent/US20100130784A1/en not_active Abandoned
- 2006-02-13 CA CA002598869A patent/CA2598869A1/en not_active Abandoned
- 2006-02-13 AU AU2006217630A patent/AU2006217630A1/en not_active Abandoned
- 2006-02-13 BR BRPI0607839-7A patent/BRPI0607839A2/pt not_active IP Right Cessation
-
2007
- 2007-07-17 IL IL184677A patent/IL184677A0/en unknown
- 2007-07-19 ZA ZA200705972A patent/ZA200705972B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0607839A2 (pt) | 2009-06-13 |
CN101128438A (zh) | 2008-02-20 |
AU2006217630A1 (en) | 2006-08-31 |
KR20070096041A (ko) | 2007-10-01 |
WO2006090250A1 (en) | 2006-08-31 |
RU2007131537A (ru) | 2009-03-27 |
US20100130784A1 (en) | 2010-05-27 |
EP1856060A1 (en) | 2007-11-21 |
CA2598869A1 (en) | 2006-08-31 |
JP2008545617A (ja) | 2008-12-18 |
IL184677A0 (en) | 2007-12-03 |
ZA200705972B (en) | 2009-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200630350A (en) | Dibenzyl amine compounds and derivatives | |
TW200508222A (en) | Quinoline and quinoxaline compounds | |
RS20050395A (en) | Ppar activators | |
TW200736235A (en) | Dibenzyl amine compounds and derivatives | |
AP2002002426A0 (en) | Ppar agonists | |
UA83202C2 (ru) | Фенилзамещенные пиперидины для использования в качестве активаторов рапп | |
WO2010079431A3 (en) | Compounds for the prevention and treatment of cardiovascular disease | |
MXPA05012570A (es) | Derivados de tetrahidroisoquinolina como activadores de ppar-a. | |
HK1136283A1 (en) | Compounds for the prevention and treatment of cardiovascular diseases | |
TW200616963A (en) | 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds | |
MY130670A (en) | 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines | |
MY121838A (en) | 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines | |
MY121405A (en) | 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines | |
HK1188985A1 (zh) | 治療細胞增殖紊亂的化合物和方法 | |
MY149960A (en) | 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamide derivatives as mek inhibitors for the treatment of hyperproliferative diseases | |
MX2009005455A (es) | (r)-n-estereoisomeros de analogos de 7,8-saturados-4,5 epoxi-morfinano. | |
AP2002002427A0 (en) | Ppar compounds. | |
MX2007010243A (es) | Compuestos de 1,1,1-trifluoro-3-[(bencil)-(pirimidin-2-il)-amino]- propan-2-ol sustituidos. | |
TW200616964A (en) | Quinoline compounds | |
TW200738652A (en) | Dibenzyl amine compounds and derivatives | |
WO2009027785A3 (en) | 1, 3-oxazole derivatives as cetp inhibitors | |
DOP2005000182A (es) | Compuestos de 4-amino-sustituido-2-sustituido-1,2,3-tetrahidroquinolina | |
UY29123A1 (es) | Compuestos de 4-amino-sustituido-2-sustituido-1,2,3,4-tetrahidroquinolina | |
NZ597776A (en) | Compounds for the prevention and treatment of cardiovascular diseases | |
DOP2004000863A (es) | Compuestos de quinolina y quinoxalina |